Which Treatment Fits Your Lifestyle and Budget?
Mounjaro Versus Wegovy: UK Stock Availability Comparison
When researching Mounjaro versus Wegovy, UK availability often becomes a primary concern. Historically, Wegovy supply has faced intermittent shortages, leaving patients uncertain about treatment continuity. EverydayMeds maintains robust stock levels for both medications through our established relationships with Novo Nordisk (Wegovy) and Eli Lilly (Mounjaro). Our inventory management ensures all five Wegovy doses remain consistently available, eliminating the anxiety of treatment interruptions.
The practical difference extends beyond availability to storage requirements. Wegovy can remain at room temperature for six weeks once removed from refrigeration, compared to Mounjaro's 21-day limit. This storage advantage makes Wegovy more suitable for frequent travellers or those with unpredictable schedules. Both treatments require identical clinical assessment processes, but your prescriber can guide the Mounjaro versus Wegovy decision based on your medical history and lifestyle factors.
Mounjaro Versus Wegovy: Transparent UK Pricing Structure
Understanding the cost difference in the Mounjaro versus Wegovy comparison helps inform your decision. Wegovy single pens start at £79.99 for the 0.25mg starter dose after applying discount code FIRST40 at checkout. The full progression costs £79.99 (0.25mg), £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), and £209.99 (2.4mg maintenance). New customers receive £40 off with FIRST40, whilst returning patients use DOSE25 for £25 savings. Bundle options like our Intro Trio (0.25mg, 0.5mg, and 1mg) provide three months of step-up dosing for £299.99.
Mounjaro pricing follows a different structure, though both medications require prescription-only access through clinical assessment. The Mounjaro versus Wegovy cost consideration should factor in long-term treatment duration, as both medications show optimal results with sustained use. Our Ultimate Stability Trio offers three 2.4mg Wegovy pens for £649.99, providing maintenance supply security. Payment plans and NHS prescription routes may influence your choice, which our clinical team discusses during consultation.
Clinical Evidence: Mounjaro Versus Wegovy Research Comparison
The scientific foundation behind the Mounjaro versus Wegovy debate centres on different mechanisms of action. Wegovy (semaglutide) demonstrated approximately 15% average weight loss in the STEP 1 trial at 68 weeks, as published by Wilding et al. in NEJM, 2021. The STEP programme encompassed diverse patient populations, showing consistent efficacy when combined with lifestyle interventions. These results established Wegovy's evidence base for MHRA licensing and NICE recommendation TA875.
Mounjaro operates through dual GIP and GLP-1 receptor activation, representing a different therapeutic approach than Wegovy's GLP-1-only mechanism. Clinical trials for each medication used different designs, populations, and endpoints, making direct comparison inappropriate. Both treatments require prescription-only access and work alongside reduced-calorie diets and increased physical activity, with individual responses varying considerably across patients.
How Wegovy Works in the Mounjaro Versus Wegovy Comparison
Wegovy functions as a GLP-1 receptor agonist, mimicking the natural incretin hormone that regulates appetite and food intake. The medication binds to GLP-1 receptors in the brain's appetite centres, promoting satiety signals that reduce hunger between meals. This mechanism slows gastric emptying, extending the feeling of fullness after smaller portions. Weekly injections maintain consistent therapeutic levels, supporting appetite regulation throughout treatment. The dose escalation from 0.25mg to 2.4mg over 16 weeks allows gradual tolerance development whilst optimising efficacy for sustainable weight management.
Streamlined Ordering Process for Mounjaro Versus Wegovy Decisions
EverydayMeds simplifies the Mounjaro versus Wegovy selection through our comprehensive online platform. The three-minute clinical assessment captures your medical history, current medications, weight management goals, and lifestyle factors relevant to treatment choice. Our prescribers review applications within three working days (24 hours with express service), providing personalised recommendations for Wegovy, Mounjaro, or alternative approaches. Once approved, next-day delivery ensures rapid treatment initiation through temperature-controlled logistics. Cold-chain packaging maintains medication integrity from our GPhC-registered facility #9012878 directly to your door, eliminating pharmacy visits and prescription delays.
Storage and Practical Considerations: Mounjaro Versus Wegovy
The practical aspects of the Mounjaro versus Wegovy decision include storage requirements, injection experience, and dose escalation schedules. Wegovy requires refrigeration at 2-8°C before first use but tolerates six weeks at room temperature below 30°C once removed, providing travel flexibility. The FlexTouch pen system offers user-friendly injection with pre-set dosing, reducing administration errors. Mandatory dose escalation progresses over 16 weeks from 0.25mg to 2.4mg maintenance, allowing gastrointestinal adaptation. Weekly injection timing remains flexible within your schedule, though consistency improves therapeutic outcomes and reduces side effect frequency.
Supply Chain Reliability in Mounjaro Versus Wegovy Availability
Historical supply disruptions have affected both medications, making reliable pharmacy partnerships essential for treatment continuity. EverydayMeds maintains direct relationships with Novo Nordisk and Eli Lilly, ensuring priority allocation during supply constraints. Our inventory forecasting anticipates demand patterns, particularly for maintenance doses where patients require uninterrupted treatment. Advanced ordering systems flag potential shortages weeks in advance, allowing proactive communication with patients and alternative sourcing.
The Mounjaro versus Wegovy supply situation has stabilised significantly throughout 2024, with both manufacturers expanding production capacity. However, choosing a pharmacy with proven supply chain management remains crucial for long-term treatment success. Our stock transparency updates appear on product pages, whilst automatic refill reminders prevent treatment gaps that could necessitate dose re-escalation.
Making Your Mounjaro Versus Wegovy Decision with Expert Support
Both Wegovy and Mounjaro are available from EverydayMeds—your prescriber can help determine which is right for you based on comprehensive assessment of your health profile. Start your clinical assessment today using discount codes FIRST40 (new customers) or DOSE25 (returning patients) at https://everydaymeds.co.uk/collections/wegovy. Our clinical team provides ongoing support throughout your weight management journey, ensuring optimal outcomes with your chosen treatment. Remember, both medications require commitment to dietary changes and physical activity for best results, representing tools within a comprehensive weight management strategy. Contact our team for personalised guidance on the Mounjaro versus Wegovy decision that suits your individual circumstances and goals.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
